SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Allos Therapeutics, Inc. and Mundipharma AG Announce Strategic Collaboration for FOLOTYN; Allos to Receive $50 Million Upfront; Potentially up to $310.5 Million